Clinical Supply Logistic Articles

  1. Fast, Secure, And Defensible: Building Decisions That Can Be Challenged Internally And Defended Externally 8/7/2026

    When clinical supply decisions face uncertainty, speed alone is not enough. Learn how governance frameworks create faster, more secure, and defensible actions.

  2. Cold Chain Excellence: Safeguarding Biologics, Cell Therapies, And Temperature-Sensitive Products In Complex Logistics 8/6/2026

    Cold chain failures can destroy biologics and cell therapies. Learn how real-time monitoring, validated packaging, and lane qualification reduce risk and protect patients.

  3. The Overlap Nobody Talks About: Packaging Decisions And Stability Budgets 8/4/2026

    Packaging decisions shape far more than product protection. Discover how stability budgets and temperature excursion planning can prevent waste and reduce trial risk.

  4. The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon. 8/3/2026

    Early-stage biotechs often overbuild systems too soon. Alicia Collins explains why flexibility, simple processes, and realistic assumptions matter most.

  5. How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies 7/31/2026

    From CAR-T to gene editing, clinical supply realities are increasingly influencing therapeutic design, scalability, and patient access.

  6. Reshoring Pressure Meets Manufacturing Reality 7/27/2026

    U.S. pharma can't reshore what domestic capacity can't absorb. Senior leaders from Takeda, Biogen, Eli Lilly, and others reveal why tariff pressure is colliding with a sterile fill-finish shortage, workforce gaps, and ADC capacity bottlenecks.

  7. CDMO Live Europe 2026: Partnerships For An Uncertain World 7/27/2026

    112 pages of executive insight from CDMO Live Europe 2026: tariffs, geopolitics, supply resilience, AI in manufacturing, and why strategic partnerships remain aspirational for most.

  8. Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report 7/27/2026

    Senior pharma leaders from Pfizer, Bayer, BioNTech and others debunk dual sourcing myths and reveal what separates strategic CDMO partnerships from transactional ones.

  9. The Fragility Of Efficiency: Why Global Clinical Supply Chains Fail In An Era Of Geopolitical Fragmentation 7/27/2026

    Global disruptions are exposing weaknesses in clinical supply chains. Learn practical strategies to build resilience, reduce waste, and protect trials from costly delays.

  10. South Africa In Clinical Trial Supply: An Underrecognized Capability 7/23/2026

    Many sponsors still plan for South Africa using outdated assumptions. Learn how current regulatory, logistics, and supply capabilities support reliable clinical trial execution.